SUDAIR PHARMA COMPANY (SPC)
SPC was established in 2014 to set-up a pharmaceutical complex focusing on local production of high-end generic drugs for cancer treatment and to produce other pharma solutions locally in the GCC to combat chronic diseases. GIC owns an equity stake of 35% in SPC.
Website : www.sudairpharma.com
in order to deliver high quality education with international accreditation in the mid-tuition fee segment. Horizon currently owns multiple schools with Good to Excellent ratings across various GCC countries with over 8,000 students. GIC is a significant founding co-investor and owns a 35% equity stake in Horizon.